Purpose/Objectives: To evaluate whether fatigue severity can serve as a cue to investigate the presence of depression in older adult patients with cancer.
Sample: 205 older adult patients with cancer and 436 older adults without cancer (aged 70 years or older).
Methods:
The diagnostic accuracy of fatigue as a proxy for depression was evaluated using sensitivity, specificity, and predictive values.
Main Research Variables:
Fatigue was measured with a visual analog scale, and depression was measured with the 15-item Geriatric Depression Scale.
Findings: Fifty-six percent of the population experienced fatigue, and 13% were depressed. For fatigue as a cue for depression, sensitivity was 82%, specificity was 47%, positive predictive value was 18%, and negative predictive value was 95%.
Conclusions:
The data confirm that fatigue is a valuable cue to investigate the presence of depression because 82% of depressed participants were correctly identified by fatigue. The assessment of fatigue severity is intuitive, quick, straightforward, and usually already implemented.
Implications for Nursing:
Identification of depression is difficult in older adult patients with cancer. Instead of experiencing affective symptoms of depression, older adult patients are more likely to disclose somatic symptoms, such as fatigue, which often overlap with cancer-related symptoms. Nurses should be aware of this problem and should be alert for the possibility of depression in older adult patients presenting with fatigue. (Mitchell et al., 2011) . Particularly in older adult patients with cancer, depression is identified as an important concern and is more prevalent compared to younger patients with cancer and older adults (aged 70 years or older) without a history of cancer (Mohile et al., 2011; Nelson et al., 2009) . Because the number of older adult patients with cancer is rising, the psychosocial consequences of cancer and its treatment, such as depression, will become an important problem that requires attention (Stanton, 2012) .
Depression has a negative impact on quality of life, cognitive functioning, and survival (Ensinck et al., 2002) . A study confirmed that, after adjustment for major clinical predictors of mortality, patients with cancer and depressive symptoms had a two-fold risk for all-cause mortality compared to patients with cancer without depressive symptoms (Mols, Husson, Roukema, & van de Poll-Franse, 2013) . Therefore, the accurate identification and treatment of depression is an essential public health issue.
However, identification of depression in older adult patients with cancer is challenging, and depression is often unrecognized and untreated (Nelson, Cho, Berk, Holland, & Roth, 2010; Warmenhoven, van Weel, Vissers, & Prins, 2013; Weinberger, Bruce, Roth, Breitbart, & Nelson, 2011; Weinberger, Roth, & Nelson, 2009) . Several reasons account for the under-recognition of depression. First, older adult patients less commonly disclose affective symptoms, such as sadness, and instead tend to present with trouble concentrating, fatigue, and lack of initiative (Nelson et al., 2010) . Second, patients and healthcare providers often assume that depressive symptoms are normal symptoms of aging (Nelson et al., 2010) . Third, the overlap between diagnostic criteria of depression and cancer-related symptoms and treatment side effects may account for 
